Pacira BioSciences Overview
Pacira BioSciences Target Price
Analysts' 12-month price predictions for PCRX.
Get informed when a big investor buys or sells
+ FollowShare Price
$23.51
Average Target Price
$32.00
36.1% upside
36.1% upside1 analysts in the last 4 months
High: $32 | Low: $32
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-01 | Needham | $32 | 36.1% upside |  |
| 2025-12-08 | Barclays | $27 | 14.8% upside | |
| 2025-02-28 | Barclays | $24 | 2.1% upside | |
| 2025-02-28 | H.C. Wainwright | $48 | 104.2% upside | |
| 2025-01-30 | Truist FinancialLes Sulewski | $25 | 6.3% upside | |
| 2024-11-07 | Piper SandlerDavid Amsellem | $12 |  49% downside | |
| 2024-09-24 | JefferiesGlen Santangelo | $18 | 23.4% downside | |
| 2024-08-13 | Truist FinancialLes Sulewski | $8 | 66% downside | |
| 2024-07-02 | H.C. WainwrightOren Livnat | $57 | 142.5% upside | |
| 2024-06-13 | JefferiesGlen Santangelo | $36 | 53.1% upside | |
| 2024-05-21 | Piper SandlerDavid Amsellem | $42 | 78.6% upside | |
| 2023-01-06 | BMO Capital | $52 | 121.2% upside | |
| 2023-01-06 | Needham | $63 | 168% upside | |